Sunil Healthcare Ltd. · BSE:SUNLOC
Sunil Healthcare — Investor Presentation (May 2016)
30 slides from Sunil Healthcare's investor presentation, May 2016
Slide 1: Sunil Healthcare Ltd. Investor Presentation – May 2016
Sunil Healthcare Ltd. Investor Presentation – May 2016
Slide 2: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sunil Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secu
Slide 3: FY16 Performance Highlights
FY16 Performance Highlights Revenue EBITDA Profit After Tax Rs. Mn. +12.4% +25.5% +31.3% 816 157 52 726 125 40 FY15 FY16 FY15 FY16 FY15 FY16 EBITDA Margin PAT Margin Cash PAT Margin 200 bps 90 bps 10 bps 19.2% 6.4% 11.0% 11.1% 17.2% 5.5% FY15 FY16 FY15 FY16 FY15 FY16 3
Slide 4: FY16 Financial Highlights
FY16 Financial Highlights In Rs. 816 Mn 157 Mn 19.2% EBITDA Margin – FY16 Revenue – FY16 EBITDA – FY16 31.3% 90 bps PAT – PAT Margin – ~81% Capacity Utilization – FY16 Vs. FY15 FY16 Vs. FY15 FY15 4
Slide 5: FY16 – Income Statement
FY16 – Income Statement Rs. Million Q4 FY16 Q4 FY15 YoY % FY16 FY15 YoY % Revenue 229 175 31.0% 816 726 12.4% Capsule 176 175 0.6% 721 619 16.5% Marketing of Food Product 53 -- 95 107 Raw Material 112 69 353 319 Employee Cost 24 23 94 86 Other Expenses 61 55 225 204 Other Income 7 6 13 8 EBITDA 39 3
Slide 6: Q4 FY16 Performance Highlights
Q4 FY16 Performance Highlights* Revenue EBITDA Profit After Tax Rs. Mn. +31.0% +16.0% -5.6% 229 39 13.0 12.3 34 175 Q4 FY15 Q4 FY16 Q4 FY15 Q4 FY16 Q4 FY15 Q4 FY16 EBITDA Margin PAT Margin Cash PAT Margin -220 bps -200 bps -210 bps 19.3% 7.4% 12.4% 17.1% 10.3% 5.4% Q4 FY15 Q4 FY16 Q4 FY15 Q4 FY16 Q4
Slide 7: Product Innovation-Latest Launch HPMC Capsules
Product Innovation-Latest Launch HPMC Capsules Newest product in SHL’s basket - Manufactured by SHL through Contract Manufacturer SHL’s brand equity & established well reputed market presence has led to quick market development Initial supplies done by SHL to Regulated markets met with favourable re
Slide 8: Our Story
@suntoc ~yv Uur story —
Slide 9: Company Snapshot
Company Snapshot 2nd Largest producer of Empty Hard Gelatin Capsules (EHGC) in India Pioneer Download of Double this awesome Lock and Triple Lock diagram. Capsules in India 02 Global Presence with ~40% Exports Revenue Recognized as a “STAR EXPORT HOUSE” by GoI Preferred Vendor for Large Pharmaceutic
Slide 10: Our Journey
Our Journey 2013 – Entered Foods Business with Sunloc foods. 2010-15 State of the Art HVAC System Renewed interest in the Focusing on “Quality business with an aim to 2003 Assurance and become top 3 Automation” manufactures of capsules in India Focus on increasing export 1990’s revenues
Slide 11: Management Team
Management Team Mr. Anil Khaitan - Promoter and Chairman cum Managing Director Mr. Anil Khaitan is an MBA from IMD, Geneva, 1981 Over 37 years of wide experience in Industries ranging from Steel, Copper, Paper, Jute, Wires, Foods, Pharmaceutical and Retail Vice President : PHD Chamber of Comme
Slide 12: Core Competencies to lead GROWTH
Core Competencies to lead GROWTH 01 02 03 Huge Industry Potential Wide Product Range Unique Product Offering 04 State of Art 05 06 Quality Focus Regulatory Certifications Manufacturing Facility 07 08 09 Global Presence Marque Clientele Brownfield Expansion 10 12 Economies of Scale 12
Slide 13: Huge Industry Potential
01 Huge Industry Potential Pharma exports were pegged at US$ 15 bn with a CAGR of 15% over the last 5 years Indian Pharma market is expected to grow at a CAGR of 13.6% - US$ 50 bn in 2020 In India, manufacturing cost is competitive as compared to the Western countries. Cost of innovation is 5t
Slide 14: Wide Product Range
02 Wide Product Range We offer all range of capsules and TSE Free Preservative Free Stick Free have abilities to customise products Capsules can be transparent, coloured (same or different), SLS Free Liquid Filled Pearl Finished partially opaque or completely opaque Sizes Available - 00,OSEL,
Slide 15: Unique Product Offering
03 Unique Product Offering Product Product Range caters to Pharma & Food Supplement Industry Customize Strengths and Appearance can be modified as per client requirement Suitability Suitable for filling on high speed machines with capacities upto 3,00,000 caps/hr Printing Linear, Circular & 360 degr
Slide 16: State of Art Manufacturing Facility
04 State of Art Manufacturing Facility WHO-GMP certified facility Zero Discharge with fully automated ‘ETP’ Latest Generation PLC controlled high- speed automatic machines State of Art HVAC system from Kruger, Trane, Carrier, Zeco Experienced Six Sigma Qualified team 22 automatic product
Slide 17: Quality Focus
05 Quality Focus Internationally Accepted Measures TPAM, 5S, Jishu Hozen across Stringent Quality Compliance Measures Adopted for production lines “zero defect” capsules Six Sigma, for process control and Process R&D: Industry Leader for efficient utilization product control of primary raw m
Slide 18: Regulatory Certifications
06 Regulatory Certifications ISO-22000:2005 WHO-GMP ISO-14001:2004 NSF /9001:2008 TGA US FDA-DMF TYPE-IV Health Canada GDP AUSTRALIA Halal-JAKIM GLP OHSAS 18001:2007 Malaysia 18
Slide 19: Certifications – Raw Material (Gelatin)
Certifications – Raw Material (Gelatin) HALAL KOSHER Gluten EDQM Free Aflatoxin Veterinary BSE/TSE FREE 19
Slide 20: Global Presence
07 Global Presence Presence in Over 30 Countries across the Globe Recognized Star Export House 20
Slide 21: Marquee Clientele
08 Marquee Clientele @suntoc Wyeth = @...., CD Abbott © CADILA A Promise for Life Expressions for healthy fe —— PHARMACEUTICALS =
Slide 22: Brownfield Capacity Expansion Completed
09 Brownfield Capacity Expansion Completed 10 Capacity Expansion at end of FY16 at 10 billion capsules p.a 2.3 7.7 In Q4 FY16, achieved a capacity utilization rate of ~81% and expect to maintain momentum going forward Capacity Expansion – to drive increased revenue streams with margin expansio
Slide 23: Economies of Scale
10 Economies of Scale 10 billion p.a Capsules Capacity at a Single Location at Alwar, Rajasthan Infrastructure Human Resource 01 Common Infrastructure and Utilities Shared Commercial & 02 Technical Resources Control 03 Better Control and Smooth Running of the Plant Procurement & Dispatch Better Nego
Slide 24: Sunloc Foods - (A division of Sunil Healthcare)
Sunloc Foods - (A division of Sunil Healthcare) Division started in 2013 Engaged in marketing of Nuts, mainly Cashews Building Capabilities in Supply Chain 11.7 % Revenue Contribution in FY16 24
Slide 25: FY16 – Building Strength
FY16 – Building Strength Brownfield Expansion Completed Driving growth with profitability HPMC product Launched Supplied and Delivered to new overseas geographies Credit Rating Moves Up Credit Rating moved a notch up, reaffirming our growing stability Healthcare Leadership Award Won “The Best Use of
Slide 26: Business Excellence Awards
Business Excellence Awards Healthcare Leadership Award – Six Sigma Won “The Best Use of Six Sigma In Healthcare Award at the Healthcare Leadership Awards, hosted by ABP News November 2015” Business Excellence Award 2015 Received the prestigious “Business Excellence Award 2015 for Excellence in Manuf
Slide 27: Business Momentum
Business Momentum In Rs. 816 Mn 157 Mn 52 Mn PAT - FY16 Revenue - FY16 EBITDA – FY16 21% Revenue 25%EBITDA 55% PAT 3 Years CAGR 3 Years CAGR 3 Years CAGR 27
Slide 28: Annual Income Statement
Annual Income Statement Rs. Million FY16 FY15 FY14 FY13 Revenue 816 726 617 461 Raw Material 353 319 214 141 Employee Cost 94 86 71 62 Other Expenses 225 204 220 186 Other Income 13 8 5 9 EBITDA 157 125 117 81 EBITDA Margin 19.2% 17.2% 19.0% 17.5% Interest 38 23 25 26 Depreciation 39 40 41 38 Except
Slide 29: Balance Sheet
Balance Sheet Rs. Million FY16 FY15 FY14 FY13 Shareholders Fund 310 258 231 198 Share Capital 102 102 102 102 Reserves & Surplus 208 156 129 96 Total Non Current Liabilities 132 82 66 73 Long Term Borrowings 92 57 38 43 Other Long Term Liabilities 40 25 28 30 Total Current Liabilities 415 295 260 26
Slide 30: For further information, please contact:
For further information, please contact: Company : Investor Relations Advisors : Sunil Healthcare Ltd. Strategic Growth Advisors Pvt. Ltd. CIN - L24302DL1973PLC189662 CIN - U74140MH2010PTC204285 Mr. Pawan Rathi, Chief Financial Mr. Shogun Jain / Ms. Sanjita Ghosh Officer jshogun@sgapl.net / gsanjita